Using fragment-based drug discovery to identify small molecule inhibitors of SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase (RdRp) and future starting points for other Coronaviruses

Therapeutic Innovation Australia 2026 Open access

Read full text

Authors: Therapeutic Innovation Australia

DOI: 10.82292/0rjv-pk12

Cited by: 0

Fields of Study & Subjects

Computational Drug Discovery Methods SARS-CoV-2 and COVID-19 Research SARS-CoV-2 detection and testing